Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7983993rdf:typepubmed:Citationlld:pubmed
pubmed-article:7983993lifeskim:mentionsumls-concept:C0422792lld:lifeskim
pubmed-article:7983993lifeskim:mentionsumls-concept:C0023290lld:lifeskim
pubmed-article:7983993lifeskim:mentionsumls-concept:C1708063lld:lifeskim
pubmed-article:7983993lifeskim:mentionsumls-concept:C0030895lld:lifeskim
pubmed-article:7983993lifeskim:mentionsumls-concept:C0085795lld:lifeskim
pubmed-article:7983993pubmed:issue8937lld:pubmed
pubmed-article:7983993pubmed:dateCreated1995-1-5lld:pubmed
pubmed-article:7983993pubmed:abstractTextPatients do not always respond to treatment of visceral leishmaniasis with pentavalent antimony, and the drug has toxic effects. Amphotericin B might be useful as an alternative first-line treatment for the disease. We compared the efficacy of amphotericin and sodium stibogluconate in a prospective randomised trial in 80 uncomplicated and parasitologically confirmed cases of Indian kala-azar. None of the patients had received an antileishmanial agent before. Sodium stibogluconate was given at 20 mg/kg in two divided doses daily for 40 days, and amphotericin in fourteen doses of 0.5 mg/kg infused in 5% dextrose on alternate days. All 40 patients randomised to amphotericin were cured; of the 40 patients assigned to sodium stibogluconate, 28 (70%) showed initial cure and 25 (62.5%) showed definitive cure (p < 0.001). With amphotericin, there was quicker abatement of fever and more complete spleen regression with no serious adverse effects. Amphotericin is effective in the first-line treatment of Indian kala-azar and superior to antimony therapy.lld:pubmed
pubmed-article:7983993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7983993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7983993pubmed:languageenglld:pubmed
pubmed-article:7983993pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7983993pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7983993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7983993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7983993pubmed:statusMEDLINElld:pubmed
pubmed-article:7983993pubmed:monthDeclld:pubmed
pubmed-article:7983993pubmed:issn0140-6736lld:pubmed
pubmed-article:7983993pubmed:authorpubmed-author:KhanA BABlld:pubmed
pubmed-article:7983993pubmed:authorpubmed-author:MishraMMlld:pubmed
pubmed-article:7983993pubmed:authorpubmed-author:BiswasU KUKlld:pubmed
pubmed-article:7983993pubmed:authorpubmed-author:JhaA MAMlld:pubmed
pubmed-article:7983993pubmed:issnTypePrintlld:pubmed
pubmed-article:7983993pubmed:day10lld:pubmed
pubmed-article:7983993pubmed:volume344lld:pubmed
pubmed-article:7983993pubmed:ownerNLMlld:pubmed
pubmed-article:7983993pubmed:authorsCompleteYlld:pubmed
pubmed-article:7983993pubmed:pagination1599-600lld:pubmed
pubmed-article:7983993pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:meshHeadingpubmed-meshheading:7983993-...lld:pubmed
pubmed-article:7983993pubmed:year1994lld:pubmed
pubmed-article:7983993pubmed:articleTitleAmphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.lld:pubmed
pubmed-article:7983993pubmed:affiliationDarbhanga Medical College and Hospital, Bihar, India.lld:pubmed
pubmed-article:7983993pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7983993pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7983993pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7983993pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7983993lld:pubmed